⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNTI News
Senti Biosciences, Inc. Common Stock
Form 8-K
sec.gov
SNTI
Form 8-K
sec.gov
SNTI
Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase
globenewswire.com
SNTI
Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program
globenewswire.com
SNTI
Form 8-K
sec.gov
SNTI
Form 8-K12B
sec.gov
SNTI
Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026
globenewswire.com
SNTI
Form 8-K
sec.gov
SNTI
Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies
globenewswire.com
SNTI
Form 8-K
sec.gov
SNTI